GLAXOSMITHKLINE S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.08 EGP | +3.32% |
|
+0.97% | -12.57% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.82B 38.25M | Sales 2023 | 2.24B 47M | Capitalization | 2.97B 62.28M |
|---|---|---|---|---|---|
| Net income 2022 | 735M 15.42M | Net income 2023 | 60M 1.26M | EV / Sales 2022 | 1.46 x |
| Net cash position 2022 | 516M 10.83M | Net cash position 2023 | 732M 15.36M | EV / Sales 2023 | 1 x |
| P/E ratio 2022 |
4.33
x | P/E ratio 2023 |
49.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
2.11% | Free-Float | 2.91% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.32% | ||
| 1 week | +0.97% | ||
| Current month | +3.32% | ||
| 1 month | +3.50% | ||
| 3 months | -19.25% | ||
| 6 months | -1.89% | ||
| Current year | -12.57% |
1 week
29.96
31.50
1 month
29.1936.00
Current year
28.2047.50
1 year
26.2647.50
3 years
16.6647.50
5 years
5.7747.50
10 years
0.0047.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chairman | - | - | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 31.4 | +1.03% | 12,765 |
| 24-05-02 | 31.08 | +3.32% | 13,224 |
| 24-05-01 | 30.08 | 0.00% | 9,013 |
| 24-04-30 | 30.08 | -2.27% | 21,406 |
| 24-04-29 | 30.78 | -0.36% | 26,723 |
End-of-day quote Egyptian Exchange, May 01, 2024
More quotes
GlaxoSmithKline Egypt S.A.E. specializes in the development, manufacture and marketing of medicines. Their products are for the treatment of diabetes, asthma, cancer, hepatic viruses, infections, allergies and gastro-intestinal and cardiovascular diseases.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -12.57% | 54.13M | |
| +31.52% | 690B | |
| +24.70% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +13.96% | 235B | |
| +5.38% | 199B | |
| -10.02% | 195B | |
| +3.98% | 161B |
- Stock Market
- Equities
- BIOC Stock